Wave Life Sciences (WVE) Change in Account Payables (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Change in Account Payables data on file, last reported at $1.6 million in Q2 2026.

• Quarterly Change in Account Payables rose 468.12% year-over-year to $1.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.1 million (up 278.9% YoY) and the FY2025 annual result came in at -$561000.0, down 116.4% from the prior year.
• Change in Account Payables eased to $1.6 million in Q2 2026, from $3.3 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $6.1 million in Q2 2024 to a low of -$5.1 million in Q3 2024.
• A 5-year average of $739111.1 and a median of $638500.0 in 2022 frame the typical range for Change in Account Payables.
• The widest YoY moves for Change in Account Payables: up 2701.38% in 2024, down 1109.54% in 2024.
• Tracing WVE's Change in Account Payables over 5 years: stood at $1.0 million in 2022, then slumped by 81.01% to $192000.0 in 2023, then jumped by 1702.08% to $3.5 million in 2024, then plunged by 66.59% to $1.2 million in 2025, then soared by 35.64% to $1.6 million in 2026.
• The last three Change in Account Payables figures came in at $1.6 million (Q2 2026), $3.3 million (Q1 2026), and $1.2 million (Q4 2025), per Business Quant data.